DMK PHARMACEUTICALS Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
DMK PHARMACEUTICALS Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • DMK PHARMACEUTICALS Corp Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $146K, a 70% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $146K -$340K -70% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $232K -$336K -59.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $318K -$333K -51.2% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $402K -$329K -45% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $486K -$816K -62.7% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $569K -$854K -60% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $650K -$320K -32.9% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $732K -$803K -52.3% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $1.3M -$345K -20.9% Jun 30, 2021 10-Q 2021-11-22
Q1 2021 $1.42M -$335K -19.1% Mar 31, 2021 10-Q 2021-11-22
Q4 2020 $970K -$897K -48.1% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.53M -$442K -22.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.65M -$438K -21% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 $1.76M -$43.4K -2.41% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 $1.87M Dec 31, 2019 10-K 2021-04-15
Q3 2019 $1.98M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.08M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.8M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.